Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nicholas A. Trahearn"'
Autor:
Sidra Nawaz, Nicholas A. Trahearn, Andreas Heindl, Susana Banerjee, Carlo C. Maley, Andrea Sottoriva, Yinyin Yuan
Publikováno v:
EBioMedicine, Vol 48, Iss , Pp 224-235 (2019)
Background: Despite treatment advances, there remains a significant risk of recurrence in ovarian cancer, at which stage it is usually incurable. Consequently, there is a clear need for improved patient stratification. However, at present clinical pr
Externí odkaz:
https://doaj.org/article/704d0afd473e4cad85d11af14f6cf40b
Autor:
Javier Fernández-Mateos, Andrea Sottoriva, Carlo C. Maley, Inmaculada Spiteri, Udai Banerji, Benjamin Werner, Ahmet Acar, Mark Stubbs, Luca Magnani, Sung Pil Hong, Giulio Caravagna, Adam Stewart, Nicholas A. Trahearn, Daniel Nichol, Nicola Valeri, Georgios Vlachogiannis, Rosemary Burke, George D. Cresswell, Iros Barozzi
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-14 (2020)
Nature Communications
Nature Communications
Drug resistance mediated by clonal evolution is arguably the biggest problem in cancer therapy today. However, evolving resistance to one drug may come at a cost of decreased fecundity or increased sensitivity to another drug. These evolutionary trad
Autor:
Haider Tari, Maria Vinci, Nicholas A. Trahearn, Benjamin Werner, Chris Jones, Ketty Kessler, Andrea Sottoriva
Publikováno v:
Cell reports. 40(9)
Intra-tumour heterogeneity is an intrinsic property of all cancers. In some cases, such variation can be maintained by interactions between tumour subclones with distinct molecular and phenotypic characteristics. In paediatric gliomas, interactions c
Autor:
Andreas Heindl, Susana Banerjee, Yinyin Yuan, Carlo C. Maley, Sidra Nawaz, Andrea Sottoriva, Nicholas A. Trahearn
Publikováno v:
EBioMedicine, Vol 48, Iss, Pp 224-235 (2019)
EBioMedicine
EBioMedicine
Background: Despite treatment advances, there remains a significant risk of recurrence in ovarian cancer, at which stage it is usually incurable. Consequently, there is a clear need for improved patient stratification. However, at present clinical pr